Drugs / V0355
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02518568 | Aug 2015 → May 2016 | iron deficiency anemia | Pierre Fabre Laboratories | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V0355 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02518568 ↗ |
| Known as | Ferrous Sulphate Supplement | “Ferrous Sulphate Supplement (V0355)” NCT02518568 ↗ |
| Route | Oral | “single oral administration” NCT02518568 ↗ |